COVID-19 is an acute infectious respiratory disease caused by infection with coronavirus subtype SARS-CoV-2. Transmission happens through respiratory droplets mainly via sneezing, coughing, not washing of hands after long periods, and rubbing unwashed hands on eyes, just to name a few. The disease has a wide spectrum of severity, starting with mild symptoms that can progress to more severe courses. Patients start presenting with dry cough, difficulty of breathing or dyspnea, fever, headache, fatigue, and with some presenting with loss of smell/taste. Obesity can cause activation and dysregulation of the immune system through the release of cytokines like tumor necrosis factor (TNF-α), IL-1β, and IL-6 which can cause acute inflammatory response [1]. Inflammation triggers unsustainable immune response to viral infections [1] like COVID-19; hence, these very high levels of cytokines (cytokine storm) [1] can promote organ failure and raise mortality rates among obese African Americans.
Clinical courses can happen between developing mild symptoms and life-threatening complications which can include acute respiratory distress syndrome (ARDS), aseptic shock, and with some patients suffering organ failure. Patients who experience severe disease symptoms often present with dyspnea, cyanosis, mental status changes, chest uneasiness, and increased respiratory rates of ˃ 22/min along with respiratory distress of SPO2 ≤ 93%. Severe symptoms need admissions with close monitoring since currently no definite treatment option exists. Men and women are equally affected [2] across all racial groups; however, the African American obese population within the city of Detroit, Michigan, has a higher mortality rate.
SARS-CoV-2 is a subfamily of enveloped nonsegmented positive-sense RNA viruses that cause respiratory tract infections that can range from mild to severe courses [1]. SARS-CoV-2 shares 79.5% identity to the SARS-CoV genome [1]. The virus invades host cells via angiotensin-converting enzyme 2 (ACE2) [1]. Increased concentrations of ACE2, which is expressed in the surface epithelium of the lungs, heart, and mucous membranes of gastrointestinal tract (hence could explain diarrhea symptoms) and upper respiratory tract (could be responsible for continuous viral shedding), play a role in the pathogenesis of COVID-19 [1].